Struve Clayton A 4

Accession 0001560637-12-000002

CIK 0000830656other

View on SEC.gov Company Profile

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 2:18 PM ET

Size

62.0 KB

Accession

0001560637-12-000002

Insider Transaction Report

Form 4

Period: 2012-04-10

PRESSURE BIOSCIENCES INCPBIO

Struve Clayton A

10% Owner

Transactions

Purchase
Common Stock
2012-04-10$0.55/sh+2,000$1,100→ 102,585 total(indirect: By LLC)
Purchase
Common Stock
2012-04-20$0.52/sh+2,000$1,040→ 123,785 total(indirect: By LLC)
Purchase
Common Stock
2012-04-25$0.41/sh+8,000$3,280→ 131,785 total(indirect: By LLC)
Purchase
Common Stock
2012-09-10$0.28/sh+10,000$2,800→ 162,935 total(indirect: By LLC)
Other
Common Stock
2012-09-28+27,816→ 1,051,665 total
Purchase
Common Stock
2012-10-04$0.29/sh+10,000$2,900→ 174,935 total(indirect: By LLC)
Other
Promissory Note - Aug 2011 Common Stock Warrant
2012-07-06−211,765→ 0 total
Exercise: $0.85Exp: 2014-08-03→ Common Stock (211,765 underlying)
Other
February 2012 Common Stock Purchase Warrant
2012-07-06−200,001→ 0 total
Exercise: $0.74Exp: 2012-08-07→ Common Stock (200,001 underlying)
Purchase
Common Stock
2012-04-13$0.60/sh+2,000$1,200→ 108,585 total(indirect: By LLC)
Purchase
Common Stock
2012-04-19$0.46/sh+9,200$4,200→ 121,785 total(indirect: By LLC)
Purchase
Common Stock
2012-04-24$0.47/sh+2,000$940→ 133,785 total(indirect: By LLC)
Purchase
Common Stock
2012-05-10$0.42/sh+4,000$1,680→ 137,785 total(indirect: By LLC)
Purchase
Common Stock
2012-05-11$0.42/sh+2,000$840→ 139,785 total(indirect: By LLC)
Purchase
Common Stock
2012-05-14$0.40/sh+2,000$800→ 141,785 total(indirect: By LLC)
Purchase
Common Stock
2012-06-06$0.21/sh+150$32→ 141,935 total(indirect: By LLC)
Purchase
Common Stock
2012-06-18$0.25/sh+5,000$1,250→ 146,935 total(indirect: By LLC)
Purchase
Common Stock
2012-08-28$0.28/sh+2,000$560→ 150,935 total(indirect: By LLC)
Purchase
Common Stock
2012-09-04$0.29/sh+2,000$580→ 152,935 total(indirect: By LLC)
Other
Series C Common Stock Purchase Warrant
2012-07-06−311,925→ 0 total
Exercise: $0.74Exp: 2017-08-07→ Common Stock (311,925 underlying)
Other
Series C Common Stock Purchase Warrant
2012-07-06+311,925→ 311,925 total
Exercise: $0.60Exp: 2017-08-07→ Common Stock (311,925 underlying)
Other
Promissory Note - Aug 2011 Common Stock Warrant
2012-07-06+211,765→ 211,765 total
Exercise: $0.60Exp: 2014-08-03→ Common Stock (211,765 underlying)
Purchase
Common Stock
2012-04-11$0.55/sh+4,000$2,200→ 106,585 total(indirect: By LLC)
Purchase
Common Stock
2012-04-16$0.53/sh+4,000$2,120→ 112,585 total(indirect: By LLC)
Purchase
Common Stock
2012-07-23$0.28/sh+2,000$560→ 148,935 total(indirect: By LLC)
Purchase
Common Stock
2012-09-18$0.25/sh+2,000$500→ 164,935 total(indirect: By LLC)
Purchase
Common Stock
2012-10-08$0.29/sh+2,000$580→ 176,935 total(indirect: By LLC)
Other
Promissory Note - Aug 2011 Common Stock Warrant
2012-07-06−26,316→ 0 total
Exercise: $0.76Exp: 2014-08-03→ Common Stock (26,316 underlying)
Other
The reported transactions involved an amendment of an outsta
2012-07-06+26,316→ 23,316 total
Exercise: $0.60Exp: 2014-08-03→ Common Stock (26,316 underlying)
Other
February 2012 Common Stock Warrant
2012-07-06+200,001→ 200,001 total
Exercise: $0.60Exp: 2017-08-07→ Common Stock (200,001 underlying)

CSS LLC/IL

Other

Transactions

Purchase
Common Stock
2012-04-19$0.46/sh+9,200$4,200→ 121,785 total(indirect: By LLC)
Other
Common Stock
2012-09-28+27,816→ 1,051,665 total
Purchase
Common Stock
2012-10-08$0.29/sh+2,000$580→ 176,935 total(indirect: By LLC)
Other
Promissory Note - Aug 2011 Common Stock Warrant
2012-07-06+211,765→ 211,765 total
Exercise: $0.60Exp: 2014-08-03→ Common Stock (211,765 underlying)
Purchase
Common Stock
2012-04-10$0.55/sh+2,000$1,100→ 102,585 total(indirect: By LLC)
Purchase
Common Stock
2012-04-13$0.60/sh+2,000$1,200→ 108,585 total(indirect: By LLC)
Purchase
Common Stock
2012-04-16$0.53/sh+4,000$2,120→ 112,585 total(indirect: By LLC)
Purchase
Common Stock
2012-04-24$0.47/sh+2,000$940→ 133,785 total(indirect: By LLC)
Purchase
Common Stock
2012-10-04$0.29/sh+10,000$2,900→ 174,935 total(indirect: By LLC)
Other
February 2012 Common Stock Warrant
2012-07-06+200,001→ 200,001 total
Exercise: $0.60Exp: 2017-08-07→ Common Stock (200,001 underlying)
Purchase
Common Stock
2012-06-06$0.21/sh+150$32→ 141,935 total(indirect: By LLC)
Purchase
Common Stock
2012-06-18$0.25/sh+5,000$1,250→ 146,935 total(indirect: By LLC)
Purchase
Common Stock
2012-08-28$0.28/sh+2,000$560→ 150,935 total(indirect: By LLC)
Purchase
Common Stock
2012-09-10$0.28/sh+10,000$2,800→ 162,935 total(indirect: By LLC)
Other
The reported transactions involved an amendment of an outsta
2012-07-06+26,316→ 23,316 total
Exercise: $0.60Exp: 2014-08-03→ Common Stock (26,316 underlying)
Purchase
Common Stock
2012-04-11$0.55/sh+4,000$2,200→ 106,585 total(indirect: By LLC)
Purchase
Common Stock
2012-04-20$0.52/sh+2,000$1,040→ 123,785 total(indirect: By LLC)
Purchase
Common Stock
2012-04-25$0.41/sh+8,000$3,280→ 131,785 total(indirect: By LLC)
Purchase
Common Stock
2012-05-10$0.42/sh+4,000$1,680→ 137,785 total(indirect: By LLC)
Purchase
Common Stock
2012-05-11$0.42/sh+2,000$840→ 139,785 total(indirect: By LLC)
Purchase
Common Stock
2012-05-14$0.40/sh+2,000$800→ 141,785 total(indirect: By LLC)
Purchase
Common Stock
2012-07-23$0.28/sh+2,000$560→ 148,935 total(indirect: By LLC)
Purchase
Common Stock
2012-09-04$0.29/sh+2,000$580→ 152,935 total(indirect: By LLC)
Purchase
Common Stock
2012-09-18$0.25/sh+2,000$500→ 164,935 total(indirect: By LLC)
Other
Series C Common Stock Purchase Warrant
2012-07-06−311,925→ 0 total
Exercise: $0.74Exp: 2017-08-07→ Common Stock (311,925 underlying)
Other
Series C Common Stock Purchase Warrant
2012-07-06+311,925→ 311,925 total
Exercise: $0.60Exp: 2017-08-07→ Common Stock (311,925 underlying)
Other
Promissory Note - Aug 2011 Common Stock Warrant
2012-07-06−211,765→ 0 total
Exercise: $0.85Exp: 2014-08-03→ Common Stock (211,765 underlying)
Other
Promissory Note - Aug 2011 Common Stock Warrant
2012-07-06−26,316→ 0 total
Exercise: $0.76Exp: 2014-08-03→ Common Stock (26,316 underlying)
Other
February 2012 Common Stock Purchase Warrant
2012-07-06−200,001→ 0 total
Exercise: $0.74Exp: 2012-08-07→ Common Stock (200,001 underlying)

Footnotes (9)

[F1]Reporting Person, Clayton Struve, is an Indirect Owner as Member Manager of CSS, LLC of shares purchased by CSS, LLC. CSS,LLC disclaims any beneficial ownership (direct or indirect) of shares held directly by Reporting Person, Clayton Struve.
[F2]Dividend shares as a result of investment in Series C Preferred shares.
[F3]Dividend accrual of $22,322 at a rate of .8025 or 27,816 shares
[F4]The reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the old warrant at an exercise price of $0.74 and the grant of a replacement warrant at an exercise price of $0.60.
[F5]The Series C Common Stock Purchase Warrants contain a limitation on exercise which prevents the Reporting Person from exercising any Warrants if, after giving effect to the exercise, the Reporting Person would beneficially own more than 4.99% of the outstanding shares of Common Stock. The Reporting Person may elect to increase this limitation to 9.99%, 14.99% or 19.99%, upon not less than 61 days prior written notice to the Company. Since the Reporting Person currently beneficially owns more than 9.99% but less than 14.99% of the outstanding shares of Common Stock, the conversion limitation that applies to the Reporting Person is the 14.99% limitation. The Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest in such securities
[F6]The reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the old warrant at an exercise price of $0.85 and the grant of a replacement warrant at an exercise price of $0.60.
[F7]The Promissory Note-Aug 2011 Common Stock Purchase Warrants contain a limitation on exercise which prevents the Reporting Person from exercising any Warrants if, after giving effect to the exercise, the Reporting Person would beneficially own more than 4.99% of the outstanding shares of Common Stock. The Reporting Person may elect to increase this limitation to 9.99%, 14.99% or 19.99%, upon not less than 61 days prior written notice to the Company. Since the Reporting Person currently beneficially owns more than 9.99% but less than 14.99% of the outstanding shares of Common Stock, the conversion limitation that applies to the Reporting Person is the 14.99% limitation. The Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest in such securities
[F8]The reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the old warrant at an exercise price of $0.76 and the grant of a replacement warrant at an exercise price of $0.60
[F9]The February 2012 Common Stock Purchase Warrants contain a limitation on exercise which prevents the Reporting Person from exercising any Warrants if, after giving effect to the exercise, the Reporting Person would beneficially own more than 4.99% of the outstanding shares of Common Stock. The Reporting Person may elect to increase this limitation to 9.99%, 14.99% or 19.99%, upon not less than 61 days prior written notice to the Company. Since the Reporting Person currently beneficially owns more than 9.99% but less than 14.99% of the outstanding shares of Common Stock, the conversion limitation that applies to the Reporting Person is the 14.99% limitation. The Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest in such securities

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

PRESSURE BIOSCIENCES INC

CIK 0000830656

→

Entity typeother

Related Parties

filerCIK 0001560637

Filing Metadata

Form type: 4
Filed: Nov 20, 7:00 PM ET
Accepted: Nov 21, 2:18 PM ET
Size: 62.0 KB

View on SEC.gov